Navigation Links
Study finds breast cancer incidence rates no longer declining in US women
Date:2/28/2011

ATLANTA February 28, 2011 A sharp decline in breast cancer incidence rates among non-Hispanic white women in the U.S. after a dramatic drop in the use of postmenopausal hormone therapy did not continue through 2007, according to a new study from the American Cancer Society and the National Cancer Institute. While there are several possible explanations for the recent stabilization, it may indicate that the decrease in breast cancers thought to be related to postmenopausal hormone use has bottomed out. The study appears online in Cancer Epidemiology Biomarkers and Prevention and will appear in a future print issue.

Breast cancer incidence rates among U.S. white women dropped by about 7% between 2002 and 2003 after a dramatic drop in the use of postmenopausal hormone therapy (HT) prompted by the Women's Health Initiative (WHI) study findings in July 2002 on the adverse health effects of combined HT use, including increased risk of breast cancer. To see if that trend continued, researchers led by Carol DeSantis, MPH reviewed data on female invasive breast cancer incidence obtained from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) 12 registries for the years 2000-2007. They found the sharp decline in breast cancer incidence rates in non-Hispanic white women between 2002 and 2003 did not continue between 2003 and 2007. There was no significant change in the overall incidence rate for breast cancer among non-Hispanic white women during those years. Meanwhile, non-Hispanic Black and Hispanic women did not experience the steep drop in incidence from 2002-2003 and there were no significant changes in incidence rates among those groups from 2003-2007.

The authors say there are several possible explanations for the recent stabilization in breast cancer incidence rates among non-Hispanic white women in the U.S. First, although the report indicates that postmenopausal HT use has continued to decline through 2008, the decrease in HT use after 2003 may not have been large enough to continue delaying diagnoses. Second, the trends may reflect improved sensitivity of mammography without influence of HT, since HT increases breast density and compromises the diagnostic performance of mammograms and breast biopsies. Also, the rates may in part reflect the relatively stable rates of screening mammography in the U.S. since 2000. Increasing screening rates would have likely increased the number of diagnoses.


'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Related medicine news :

1. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
2. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
3. TV drama can be more persuasive than news program, study finds
4. Study carried out into biological risks of eating reptiles
5. Neuroimaging study may pave way for effective Alzheimers treatments
6. Study finds racial gaps continue in heart disease awareness
7. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
8. First blinded study of venous insufficiency prevalence in MS shows promising results
9. Soothing infants with food focus of childhood obesity study
10. People with anxiety disorder less able to regulate response to negative emotions, study shows
11. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Head Island, SC (PRWEB) , ... February 08, 2016 , ... ... and surrounding areas with a vital new community enrichment program, has teamed up with ... local women and children suffering from intimate abuse. To support all those victimized by ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... relationship-marketing firm, announced today that nominations will be accepted February 8, 2016 ... Awards. , Awards include the Information Security Executive® of the Year, ...
(Date:2/8/2016)... ... ... Discover the Rocky Mountain region’s longest running and impressive garden and home show ... to see the most incredible gardens and home improvement experts that attend this amazing ... Center - 700 14th St. Denver CO, is an exciting event that Performance Mobility ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... speaking on how healthcare companies can use newly released government data on populations ... a population and intervene and capture the value they create to succeed in ...
(Date:2/7/2016)... , ... February 07, 2016 , ... ... with the latest techniques and the most minimally invasive approaches. , Women who ... particularly after menopause. Other risk factors include surgery to the pelvic floor, connective ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... N.J. , Feb. 8, 2016  Otsuka Pharmaceutical ... announced that they have entered into a licensing agreement ... in the U.S. and Puerto Rico ... a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a new ... --> In a Phase II clinical ...
(Date:2/8/2016)... LAWRENCEVILLE, N.J. , Feb. 8, 2016   ... for healthcare professionals to guide them through GS1 Standards ... and Drug Administration (FDA) Unique Device Identification (UDI) rule. ... standards, GS1 US; Beth Gibson , senior director ... Roberts , industry development director, GS1 US ...
(Date:2/8/2016)... MEMPHIS, Tenn. , Feb. 8, 2016  A ... Hospital scientists has discovered details of how the ... cells triggers a particularly aggressive form of acute lymphoblastic ... cells, in which genetic mutations trigger overproduction of immature ... --> The discoveries of the malfunction underlying the ...
Breaking Medicine Technology: